featured
Risk of Mortality or Rehospitalization After Acute Coronary Syndrome With Glyburide vs Gliclazide Use in Adults With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Glyburide use is associated with a greater likelihood of mortality or rehospitalization after acute coronary syndrome compared to gliclazide use in adults with type 2 diabetes: A cohort study
Diabetes Obes Metab 2024 Sep 09;[EPub Ahead of Print], W Long, PE Light, SH SimpsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.